Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FPX4E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,279
Award facts
- Contract value 100% obligated
- $16,278.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, issued on January 29, 2026, awards $16,278.84 to AmerisourceBergen Drug Corp for the procurement of Zepbound (semaglutide) 12.5 mg/0.5 ml pen injectors. The contract was funded by the Defense Logistics Agency (DLA) under a firm fixed-price structure with no set-aside designation, indicating competitive award through open competition. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 30, 2026. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling delivery of a broad range of medications and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor critical to federal medical procurement. The company demonstrates significant capability in fulfilling federal healthcare requirements across multiple therapeutic domains, with an extensive portfolio of medications and medical supplies supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA's pharmaceutical supply chain relies on AmerisourceBergen as a prime vendor for delivering essential medications and medical commodities to military treatment facilities and veterans' healthcare programs, with this Zepbound order representing routine execution of the broader pharmaceutical supply contract.
Quick answers
Who was awarded contract SPE2DR26FPX4E?
SPE2DR26FPX4E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26FPX4E worth?
The government has obligated $16,279 on SPE2DR26FPX4E.
Is contract SPE2DR26FPX4E an order under another contract?
Yes. SPE2DR26FPX4E is a delivery order under SPE2DR25D1034, an indefinite delivery contract.
Was contract SPE2DR26FPX4E competed?
The extent of competition for SPE2DR26FPX4E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award